Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Catalent | Contract Pharma

What are you searching for?

Sign in
Financial News

Financial Report: Catalent

Cook Pharmica and Accucaps acquisitions drive revenue growth

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Catalent
3Q Revenues: $627.9 million (+18%)
3Q Earnings: $19.0 million (-27%)
YTD Revenues: $1.8 billion (+22%)
YTD Earnings: $0.9 million (earnings were $48.0 million YTD17)
Comments: Softgel Technologies segment sales were $228.5 million in the quarter, up 9% primarily attributable to the February 2017 Accucaps acquisition. Drug Delivery Solutions revenue was $313.6 million, up 34% primarily attributable to the Cook Pharmica acquisition which contributed 26 percentage points. Excluding the impact of the acquisition, revenue increased 3% driven by biologics offerings and improved capacity utilization for products utilizing our blow-fill-seal technology platform, partially offset by a decrease in product participation revenue and lower volumes related to the analytical development services platform. Clinical Supply Services revenue was $104.4 million in the quarter, up 7%. Growth was due to higher volume related to storage and distribution services, partially offset by volume declines related to manufacturing and packaging services, as well as lower comparator sourcing volume.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters